Brief: Shanghai Bio-Heart Biological Technology - Achieves Pre-Set Primary Clinical Endpoint- In Rct Of Bioheart-Ii
Shanghai Bio-heart Biological Technology Co Ltd 2185.HK :
* SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY - ACHIEVES
PRE-SET
PRIMARY CLINICAL ENDPOINT- IN RCT OF BIOHEART-II
Source text for Eikon: ID:
Further company coverage: 2185.HK
Recent news on Shanghai Bio-heart Biological Technology
See all newsBrief: Shanghai Bio-Heart Biological Technology Says NMPA Approves Bioheart Bioabsorbable Drug-Eluting Stents
Brief: Shanghai Bio-Heart Biological Technology Says Iberis Rdn System Completes Registration In Vietnam
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completed Registration In Thailand
Brief: Shanghai Bio-Heart Biological Technology Says Iberis RDN System Completes Registration With MHRA In UK
Brief: Shanghai Bio-Heart Biological Technology's Controlling Shareholder Increases Shareholding